Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

MEREO BIOPHARMA 4 LIMITED

Company number 11029583

Follow this company File for this company
  1. Charges
  2. Charge code 1102 9583 0002

Charge code 1102 9583 0002

Created
28 September 2018
Delivered
8 October 2018
Status
Satisfied on 17 December 2020
Transaction Filed
Registration of a charge (MR01)

Persons entitled

  • Kreos Capital V (UK) Limited

Brief description

Patent for 2-pyridone derivatives as neutrophil inhibitors and their uses, patent number 2004272484 in australia and others. Patent for the tosylate salt of a 5-pyrazilyl-2-pyridone derivative, patent number 2010215269 in australia and others. For more details please refer to the instrument.
Contains fixed charge.
Contains floating charge.
Floating charge covers all the property or undertaking of the company.
Contains negative pledge.

Additional transactions filed against this charge

Additional transactions filed against this charge (PDF links open in a new window)
Type(of transaction) Delivered(to Companies House on this date) View / Download(PDF file, link opens in new window)
Satisfaction of a charge (MR04) 17 December 2020 View PDF for Satisfaction of a charge (MR04) (4 pages)